Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B
- PMID: 15220355
- DOI: 10.1074/jbc.M406499200
Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B
Abstract
The sphingolipid ceramide negatively regulates insulin action by inhibiting Akt/protein kinase B (PKB), a serine/threonine kinase that is a central regulator of glucose uptake and anabolic metabolism. Despite considerable attention, the molecular mechanism accounting for this action of ceramide has remained both elusive and controversial. Herein we utilized deletion constructs encoding two different functional domains of Akt/PKB to identify which region of the enzyme conferred responsiveness to ceramide. Surprisingly the findings obtained with these separate domains reveal that ceramide blocks insulin stimulation of Akt/PKB by two independent mechanisms. First, using the isolated pleckstrin homology domain, we found that ceramide specifically blocks the translocation of Akt/PKB, but not its upstream activator phosphoinositide-dependent kinase-1, to the plasma membrane. Second, using a construct lacking this pleckstrin homology domain, which does not require translocation for activation, we found that ceramide stimulates the dephosphorylation of Akt/PKB by protein phosphatase 2A. Collectively these findings identify at least two independent mechanisms by which excessive ceramide accumulation in peripheral tissues could contribute to the development of insulin resistance. Moreover the results obtained provide a unifying theory to account for the numerous dissenting reports investigating the actions of ceramide toward Akt/PKB.
Similar articles
-
Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism.Mol Cell Biol. 2003 Nov;23(21):7794-808. doi: 10.1128/MCB.23.21.7794-7808.2003. Mol Cell Biol. 2003. PMID: 14560023 Free PMC article.
-
Ceramide dissociates 3'-phosphoinositide production from pleckstrin homology domain translocation.Biochem J. 2001 Mar 1;354(Pt 2):359-68. doi: 10.1042/0264-6021:3540359. Biochem J. 2001. PMID: 11171115 Free PMC article.
-
Identification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells.J Biol Chem. 2005 Jun 3;280(22):21622-8. doi: 10.1074/jbc.M414464200. Epub 2005 Mar 30. J Biol Chem. 2005. PMID: 15799971
-
Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase--significance for diabetes and cancer.Pharmacol Ther. 1999 May-Jun;82(2-3):409-25. doi: 10.1016/s0163-7258(98)00071-0. Pharmacol Ther. 1999. PMID: 10454216 Review.
-
Signaling pathways mediating insulin-stimulated glucose transport.Ann N Y Acad Sci. 1999 Nov 18;892:169-86. doi: 10.1111/j.1749-6632.1999.tb07795.x. Ann N Y Acad Sci. 1999. PMID: 10842662 Review.
Cited by
-
shRNA-mediated down-regulation of Acsl1 reverses skeletal muscle insulin resistance in obese C57BL6/J mice.PLoS One. 2024 Aug 23;19(8):e0307802. doi: 10.1371/journal.pone.0307802. eCollection 2024. PLoS One. 2024. PMID: 39178212 Free PMC article.
-
Deciphering the complex interplay of risk factors in type 2 diabetes mellitus: A comprehensive review.Metabol Open. 2024 May 19;22:100287. doi: 10.1016/j.metop.2024.100287. eCollection 2024 Jun. Metabol Open. 2024. PMID: 38818227 Free PMC article. Review.
-
Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy.Cell Metab. 2024 Jul 2;36(7):1521-1533.e5. doi: 10.1016/j.cmet.2024.04.013. Epub 2024 May 7. Cell Metab. 2024. PMID: 38718792
-
Changes in Cells Associated with Insulin Resistance.Int J Mol Sci. 2024 Feb 18;25(4):2397. doi: 10.3390/ijms25042397. Int J Mol Sci. 2024. PMID: 38397072 Free PMC article. Review.
-
A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer's disease, and their co-morbidities.Front Pharmacol. 2024 Feb 6;15:1348410. doi: 10.3389/fphar.2024.1348410. eCollection 2024. Front Pharmacol. 2024. PMID: 38379904 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous